United Therapeutics Corp. (UTHR) PT Lowered to $203 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $555.91 +1.60%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $203.00 (from $231.00) while maintaining a Buy rating.
You May Also Be Interested In
- United Therapeutics acquires Thymmune for up to $300M
- Kraken Robotics (PNG:CN) (KRKNF) PT Lowered to Cdn$13.50 at Desjardins
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR2,550 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
